Regina Takahira

Prof. Regina Takahira

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
Stelio Pacca Loureiro LunaStelio Pacca Loureiro Luna
Stelio Pacca Loureiro Luna
ABAna C. Basílio
Ana C. Basílio
PSPaulo V Steagall
Paulo V Steagall
LMLuciana P. Machado
Luciana P. Machado
FMFlávia Q. Moutinho
Flávia Q. Moutinho
CBCláudia Valéria Seullner Brandão
Cláudia Valéria Seullner Brandão
Objective—To evaluate adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Animals—36 adult dogs. Procedures—Values for CBC, urinalysis, serum biochemical urinalyses, and occult blood in feces were investigated before and 7, 30, 60, and 90 days after daily oral administration (n = 6 dogs/group) of lactose (1 mg/kg, control treatment), etodolac (15 mg/kg), meloxicam (0.1 mg/kg), carprofen (4 mg/kg), and ketoprofen (2 mg/kg for 4 days, followed by 1 mg/kg daily thereafter) or flunixin (1 mg/kg for 3 days, with 4-day intervals). Gastroscopy was performed before and after the end of treatment. Results—For serum γ-glutamyltransferase activity, values were significantly increased at day 30 in dogs treated with lactose, etodolac, and meloxicam within groups. Bleeding time was significantly increased in dogs treated with carprofen at 30 and 90 days, compared with baseline. At 7 days, bleeding time was significantly longer in dogs treated with meloxicam, ketoprofen, and flunixin, compared with control dogs. Clotting time increased significantly in all groups except those treated with etodolac. At day 90, clotting time was significantly shorter in flunixin-treated dogs, compared with lactose-treated dogs. Gastric lesions were detected in all dogs treated with etodolac, ketoprofen, and flunixin, and 1 of 6 treated with carprofen. Conclusions and Clinical Relevance—Carprofen induced the lowest frequency of gastrointestinal adverse effects, followed by meloxicam. Monitoring for adverse effects should be considered when nonsteroidal anti-inflammatory drugs are used to treat dogs with chronic pain.

Verified
Journal Article
Open access
PDF file
FBFernando Pereira Beserra
Fernando Pereira Beserra
LGLucas F. S. Gushiken
Lucas F. S. Gushiken
AVAna Júlia Vieira
Ana Júlia Vieira
DBDanilo Augusto Bérgamo
Danilo Augusto Bérgamo
PBPatrícia Luísa Bérgamo
Patrícia Luísa Bérgamo
CPClaudia H Pellizzon
Claudia H Pellizzon
Skin wound healing is a highly complex event that involves different mediators at the cellular and molecular level. Lupeol has been reported to possess different biological activities, such as anti-inflammatory, antioxidant, antidiabetic, and in vitro wound healing properties, which motivated us to proceed with in vivo studies. We aimed to investigate the wound healing effect of lupeol-based cream for 3, 7, and 14 days. Wound excisions were induced on the thoraco-lumbar region of rats and topically treated immediately after injury induction. Macroscopic, histopathological, and immunohistochemical analyses were performed. Cytokine levels were measured by ELISA and gene expression was evaluated by real-time RT-qPCR. Our results showed a strong wound-healing effect of lupeol-based cream after 7 and 14 days. Lupeol treatment caused a reduction in proinflammatory cytokines (TNF-a, IL-1β, and IL-6) and gene and protein NF-κB expression, and positively altered IL-10 levels, showing anti-inflammatory effects in the three treatment periods. Lupeol treatment showed involvement in the proliferative phase by stimulating the formation of new blood vessels, increasing the immunostaining of Ki-67 and gene expression, and immunolabeling of vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), and increasing gene expression of transforming growth factor beta-1 (TGF-β1) after seven days of treatment. Lupeol was also involved in the tissue regeneration phase by increasing the synthesis of collagen fibers noted in the three treatment periods analyzed. Our findings suggest that lupeol may serve as a novel therapeutic option to treat cutaneous wounds by regulating mechanisms involved in the inflammatory, proliferative, and tissue-remodeling phases.

23 February 2013 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CCCelso A R A Costa
Celso A R A Costa
TCThaís C Cury
Thaís C Cury
BCBruna O Cassettari
Bruna O Cassettari
RTRegina Takahira
Regina Takahira
JFJorge C Flório
Jorge C Flório
MCMirtes Costa
Mirtes Costa
The current treatments for anxiety disorders and depression have multiple adverse effects in addition to a delayed onset of action, which has prompted efforts to find new substances with potential activity in these disorders. Citrus aurantium was chosen based on ethnopharmacological data because traditional medicine refers to the Citrus genus as useful in diminishing the symptoms of anxiety or insomnia, and C. aurantium has more recently been proposed as an adjuvant for antidepressants. In the present work, we investigated the biological activity underlying the anxiolytic and antidepressant effects of C. aurantium essential oil (EO), the putative mechanism of the anxiolytic-like effect, and the neurochemical changes in specific brain structures of mice after acute treatment. We also monitored the mice for possible signs of toxicity after a 14-day treatment.

1 January 2004 in Veterinary Research
Verified
Journal Article
Open access
PDF file
CBCamilo Bulla
Camilo Bulla
RTRegina Takahira
Regina Takahira
JJJoão Pessoa Araujo Jr.
João Pessoa Araujo Jr.
LTLuzia Aparecida Trinca
Luzia Aparecida Trinca
RLRaimundo Souza Lopes
Raimundo Souza Lopes
CWCharles Edward Wiedmeyer
Charles Edward Wiedmeyer
Veterinary Research, a journal on Animal Infection

1 September 2011 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
CCCelso A.R.A. Costa
Celso A.R.A. Costa
Lucas Tadeu BidinottoLucas Tadeu Bidinotto
Lucas Tadeu Bidinotto
RTRegina Takahira
Regina Takahira
DSDaisy M.F. Salvadori
Daisy M.F. Salvadori
Luís Fernando BarbisanLuís Fernando Barbisan
Luís Fernando Barbisan
MCMirtes Costa
Mirtes Costa

1 January 1998 in Veterinary Parasitology
Verified
Journal Article
Closed access
LGLuís Gondim
Luís Gondim
AKAguemi Kohayagawa
Aguemi Kohayagawa
NANayro X Alencar
Nayro X Alencar
Alexander Welker BiondoAlexander Welker Biondo
Alexander Welker Biondo
RTRegina Takahira
Regina Takahira
SFSônia R.V Franco
Sônia R.V Franco